# A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)

> **NCT00511667** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 70 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** MK0941
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00511667
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511667, "A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00511667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*